Orac also noticed AMSA’s double standard for scientific claims, something I’ve hammered at many times in reference to their PharmFree campaign:
This is, of course, ironic given the way that AMSA makes such a big deal of mentioning evidence-based approaches when it comes to dealing with the claims of big pharma while strongly promoting non-evidence-based approaches.
To say the least it leaves a credibility gap.
No comments:
Post a Comment